Affiliation:
1. Department of Rheumatology and Immunology First Hospital of China Medical University Shenyang China
2. Department of Endocrinology and Metabolism and the Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases First Hospital of China Medical University Shenyang China
3. Department of Endocrinology China‐Japan Friendship Hospital Beijing China
Abstract
AbstractIntroductionTo examine changes in the prevalence of diabetes and the control of risk factors for diabetes over 10 years among adults in China.MethodsTwo population‐based cross‐sectional surveys were used to obtain a nationally representative sample of adults aged 20 years and older in mainland China in 2007 (n = 46 239) and 2017 (n = 73 340). Changes in the prevalence of diabetes, impaired fasting glucose, impaired glucose tolerance, and prediabetes, as diagnosed by the World Health Organization criteria, were assessed over time.ResultsThe weighted prevalence of diagnosed diabetes (3.8% vs 6.3%, p = .0001) and total diabetes (9.7% vs 11.7%, p = .005) increased among the overall population between 2007 and 2017. The weighted prevalence of undiagnosed diabetes (5.9% vs 5.4%, p = .7), impaired fasting glucose (2.7% vs 2.6%, p = .68), impaired glucose tolerance (12.7% vs 12.5%, p = .95), prediabetes (15.4% vs 15.1%, p = .79), the treatment of diabetes (34.1% vs 32.5%, p = .44), and the control of diabetes (31.1% vs 32.8%, p = .73) did not significantly change over this period. The awareness of diabetes (39.4% vs 53.6%, p = .0004) increased over 10 years among the overall population. The proportion of achieved high‐density lipoprotein cholesterol targets increased (p = .005), but the proportion of achieved body mass index (p = .01) and waist circumference (p = .0002) targets decreased significantly.ConclusionsBetween 2007 and 2017, the prevalence of total diabetes (diagnosed by the World Health Organization criteria), especially diagnosed diabetes, increased among adults in China. Although awareness of diabetes improved, effective interventions and clinical strategies are urgently required.
Funder
China Postdoctoral Science Foundation
National Natural Science Foundation of China
Subject
Endocrinology, Diabetes and Metabolism
Reference22 articles.
1. Diabetes mellitus survey in China;Zhong XL;Chin Med J (Engl),1982
2. Prevalence and Treatment of Diabetes in China, 2013-2018